No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs189398988 |
chr7:26711469-26711470 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs548270269 |
chr7:26711532-26711533 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs568192628 |
chr7:26711543-26711544 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs564282203 |
chr7:26711560-26711561 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs114735237 |
chr7:26711651-26711652 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs538166552 |
chr7:26711657-26711658 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs200947340 |
chr7:26711661-26711662 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs550351070 |
chr7:26711667-26711668 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs558446833 |
chr7:26711757-26711758 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs578249627 |
chr7:26711759-26711760 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs149926998 |
chr7:26711785-26711786 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs538922346 |
chr7:26711788-26711789 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs212842 |
chr7:26711817-26711818 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
14 |
rs566106433 |
chr7:26711828-26711829 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs534921981 |
chr7:26711848-26711849 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs554625375 |
chr7:26711925-26711926 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs181771744 |
chr7:26711931-26711932 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs34920180 |
chr7:26711949-26711950 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs79282372 |
chr7:26711953-26711954 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs557035248 |
chr7:26712031-26712032 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs577170758 |
chr7:26712086-26712087 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs545749477 |
chr7:26712120-26712121 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs559611485 |
chr7:26712149-26712150 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs185990637 |
chr7:26712161-26712162 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs189265083 |
chr7:26712167-26712168 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs561762401 |
chr7:26712274-26712275 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs17290728 |
chr7:26712415-26712416 |
Weak transcription Enhancers Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
28 |
rs573675117 |
chr7:26712450-26712451 |
Weak transcription Enhancers Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs369653146 |
chr7:26712451-26712452 |
Weak transcription Enhancers Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs550658356 |
chr7:26712471-26712472 |
Weak transcription Enhancers Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs570326375 |
chr7:26712768-26712769 |
Weak transcription Enhancers Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs532959595 |
chr7:26712775-26712776 |
Weak transcription Enhancers Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs145136719 |
chr7:26712786-26712787 |
Weak transcription Enhancers Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs566059853 |
chr7:26712865-26712866 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs77482673 |
chr7:26712870-26712871 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs73683499 |
chr7:26712877-26712878 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
37 |
rs554785116 |
chr7:26712882-26712883 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs568328310 |
chr7:26712979-26712980 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs373925509 |
chr7:26713001-26713002 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs537105310 |
chr7:26713012-26713013 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs79722498 |
chr7:26713015-26713016 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs565810736 |
chr7:26713054-26713055 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs372204241 |
chr7:26713061-26713062 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs2106907 |
chr7:26713125-26713126 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
45 |
rs528366046 |
chr7:26713175-26713176 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs539853431 |
chr7:26713192-26713193 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs6967749 |
chr7:26713194-26713195 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
48 |
rs181463230 |
chr7:26713226-26713227 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs573220562 |
chr7:26713229-26713230 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs564627311 |
chr7:26713401-26713402 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|